Credit Suisse’s EnteroMedics Inc. ETRM Stock Holding History

Credit Suisse’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-11	Closed	-$21K	–	5035
2014 Q1	$21K	Buy	+11	New	+$26K	﹤0.01%	4617

Other funds holding ETRM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Credit Suisse's ETRM Position: Q2 2014 in Review

Credit Suisse sold out of EnteroMedics Inc. (ETRM) in Q2 2014, closing a stake of 11 shares — an estimated $21K sold.

Credit Suisse first reported a position in ETRM in Q1 2014 and held it in 1 quarter. The position peaked at $21K in Q1 2014. 56 funds tracked by Wall St. Rank hold ETRM as of Q2 2014.

Credit Suisse reported no remaining EnteroMedics Inc. position as of Q2 2014 after selling out during the quarter.
Credit Suisse sold 11 EnteroMedics Inc. shares in Q2 2014, an estimated $21K.
Credit Suisse first reported a position in EnteroMedics Inc. in Q1 2014 and held it in 1 quarter.
Credit Suisse's EnteroMedics Inc. position peaked at $21K in Q1 2014.
56 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2014.

Based on Credit Suisse's 13F filing for Q2 2014, filed 11 Aug 2014.